SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,432,614 | +52.1% | 69,612 | +247.5% | 0.01% | +25.0% |
Q2 2023 | $941,857 | +3.2% | 20,031 | -7.9% | 0.00% | 0.0% |
Q1 2023 | $913,007 | +45.2% | 21,759 | +32.0% | 0.00% | 0.0% |
Q4 2022 | $628,890 | -99.9% | 16,489 | +47.9% | 0.00% | +33.3% |
Q3 2022 | $436,594,000 | -60.4% | 11,149 | -67.4% | 0.00% | -70.0% |
Q2 2022 | $1,103,368,000 | -41.1% | 34,160 | -39.6% | 0.01% | -33.3% |
Q1 2022 | $1,872,202,000 | -42.3% | 56,562 | -25.9% | 0.02% | -34.8% |
Q4 2021 | $3,246,780,000 | +11.6% | 76,323 | +16.2% | 0.02% | +4.5% |
Q3 2021 | $2,910,014,000 | -3.9% | 65,674 | +23.2% | 0.02% | -8.3% |
Q2 2021 | $3,028,597,000 | -36.1% | 53,311 | -15.8% | 0.02% | -53.8% |
Q1 2021 | $4,740,250,000 | +410.2% | 63,330 | +489.7% | 0.05% | +477.8% |
Q4 2020 | $929,117,000 | +63.1% | 10,740 | -21.6% | 0.01% | 0.0% |
Q2 2020 | $569,646,000 | +122668.5% | 13,700 | -15.2% | 0.01% | +28.6% |
Q1 2020 | $464,000 | +125.2% | 16,161 | +1146.0% | 0.01% | +250.0% |
Q1 2019 | $206,000 | -42.8% | 1,297 | -43.6% | 0.00% | 0.0% |
Q2 2018 | $360,000 | -28.7% | 2,300 | -25.0% | 0.00% | -33.3% |
Q4 2017 | $505,000 | – | 3,065 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |